{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:27Z","timestamp":1792454427172,"version":"4.5.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["1R01AT012826-01"],"award-info":[{"award-number":["1R01AT012826-01"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["1DP2AI176138-01"],"award-info":[{"award-number":["1DP2AI176138-01"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-024-00482-x","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T03:48:56Z","timestamp":1737344936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets"],"prefix":"10.1038","volume":"11","author":[{"given":"Sanya","family":"Arshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7554-7447","authenticated-orcid":false,"given":"Alok V.","family":"Joglekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"482_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/334395a0","volume":"334","author":"MM Davis","year":"1988","unstructured":"Davis, M. M. & Bjorkman, P. J. T-cell antigen receptor genes and T-cell recognition. Nature 334, 395\u2013402 (1988).","journal-title":"Nature"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0065-2776(01)78004-2","volume":"78","author":"DG Hesslein","year":"2001","unstructured":"Hesslein, D. G. & Schatz, D. G. Factors and forces controlling V(D)J recombination. Adv. Immunol. 78, 169\u2013232 (2001).","journal-title":"Adv. Immunol."},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0065-2776(08)60620-3","volume":"58","author":"P Kisielow","year":"1995","unstructured":"Kisielow, P. & von Boehmer, H. Development and selection of T cells: facts and puzzles. Adv. Immunol. 58, 87\u2013209 (1995).","journal-title":"Adv. Immunol."},{"key":"482_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF00915052","volume":"7","author":"LL Lanier","year":"1987","unstructured":"Lanier, L. L. et al. The gamma T-cell antigen receptor. J. Clin. Immunol. 7, 429\u2013440 (1987).","journal-title":"J. Clin. Immunol."},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2015.04.008","volume":"296","author":"EJ Adams","year":"2015","unstructured":"Adams, E. J., Gu, S. & Luoma, A. M. Human gamma delta T cells: Evolution and ligand recognition. Cell Immunol. 296, 31\u201340 (2015).","journal-title":"Cell Immunol."},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/358764a0","volume":"358","author":"RM Chicz","year":"1992","unstructured":"Chicz, R. M. et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764\u2013768 (1992).","journal-title":"Nature"},{"key":"482_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.iy.12.040194.001145","volume":"12","author":"VH Engelhard","year":"1994","unstructured":"Engelhard, V. H. Structure of peptides associated with class I and class II MHC molecules. Annu Rev. Immunol. 12, 181\u2013207 (1994).","journal-title":"Annu Rev. Immunol."},{"key":"482_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203\u2013216 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.coi.2021.04.012","volume":"70","author":"HV Truong","year":"2021","unstructured":"Truong, H. V. & Sgourakis, N. G. Dynamics of MHC-I molecules in the antigen processing and presentation pathway. Curr. Opin. Immunol. 70, 122\u2013128 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4049\/jimmunol.182.1.274","volume":"182","author":"EM Schmidt","year":"2009","unstructured":"Schmidt, E. M. et al. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. J. Immunol. 182, 274\u2013282 (2009).","journal-title":"J. Immunol."},{"key":"482_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/intimm\/dxq026","volume":"22","author":"J Wang","year":"2010","unstructured":"Wang, J. et al. PD-1 deficiency results in the development of fatal myocarditis in MRL mice. Int Immunol. 22, 443\u2013452 (2010).","journal-title":"Int Immunol."},{"key":"482_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","volume":"31","author":"JS Blum","year":"2013","unstructured":"Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu Rev. Immunol. 31, 443\u2013473 (2013).","journal-title":"Annu Rev. Immunol."},{"key":"482_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","volume":"22","author":"N Pishesha","year":"2022","unstructured":"Pishesha, N., Harmand, T. J. & Ploegh, H. L. A guide to antigen processing and presentation. Nat. Rev. Immunol. 22, 751\u2013764 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock, K. L., Reits, E. & Neefjes, J. Present Yourself! By MHC Class I and MHC Class II Molecules. Trends Immunol. 37, 724\u2013737 (2016).","journal-title":"Trends Immunol."},{"key":"482_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0092-8674(91)90448-8","volume":"66","author":"D Cosgrove","year":"1991","unstructured":"Cosgrove, D. et al. Mice lacking MHC class II molecules. Cell 66, 1051\u20131066 (1991).","journal-title":"Cell"},{"key":"482_CR16","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1073\/pnas.90.9.3913","volume":"90","author":"MJ Grusby","year":"1993","unstructured":"Grusby, M. J. et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl Acad. Sci. USA 90, 3913\u20133917 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"482_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/344742a0","volume":"344","author":"M Zijlstra","year":"1990","unstructured":"Zijlstra, M. et al. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344, 742\u2013746 (1990).","journal-title":"Nature"},{"key":"482_CR18","first-page":"979","volume":"277","author":"LG Spurgin","year":"2010","unstructured":"Spurgin, L. G. & Richardson, D. S. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc. Biol. Sci. 277, 979\u2013988 (2010).","journal-title":"Proc. Biol. Sci."},{"key":"482_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.0019-2805.2001.01358.x","volume":"105","author":"JH Robinson","year":"2002","unstructured":"Robinson, J. H. & Delvig, A. A. Diversity in MHC class II antigen presentation. Immunology 105, 252\u2013262 (2002).","journal-title":"Immunology"},{"key":"482_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58777-2","volume":"14","author":"RC Slieker","year":"2024","unstructured":"Slieker, R. C. et al. Reassessing human MHC-I genetic diversity in T cell studies. Sci. Rep. 14, 7966 (2024).","journal-title":"Sci. Rep."},{"key":"482_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/ng.3379","volume":"47","author":"TL Lenz","year":"2015","unstructured":"Lenz, T. L. et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat. Genet 47, 1085\u20131090 (2015).","journal-title":"Nat. Genet"},{"key":"482_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41588-022-01032-z","volume":"54","author":"K Ishigaki","year":"2022","unstructured":"Ishigaki, K. et al. HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors. Nat. Genet 54, 393\u2013402 (2022).","journal-title":"Nat. Genet"},{"key":"482_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","volume":"11","author":"JA Noble","year":"2011","unstructured":"Noble, J. A. & Valdes, A. M. Genetics of the HLA region in the prediction of type 1 diabetes. Curr. Diab Rep. 11, 533\u2013542 (2011).","journal-title":"Curr. Diab Rep."},{"key":"482_CR24","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.4049\/jimmunol.176.5.3257","volume":"176","author":"T Takaki","year":"2006","unstructured":"Takaki, T. et al. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J. Immunol. 176, 3257\u20133265 (2006).","journal-title":"J. Immunol."},{"key":"482_CR25","doi-asserted-by":"publisher","first-page":"a007732","DOI":"10.1101\/cshperspect.a007732","volume":"2","author":"JA Noble","year":"2012","unstructured":"Noble, J. A. & Erlich, H. A. Genetics of type 1 diabetes. Cold Spring Harb. Perspect. Med 2, a007732 (2012).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"482_CR26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ng.2462","volume":"44","author":"S Eyre","year":"2012","unstructured":"Eyre, S. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet 44, 1336\u20131340 (2012).","journal-title":"Nat. Genet"},{"key":"482_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42324-6","volume":"13","author":"M Inoue","year":"2023","unstructured":"Inoue, M. et al. Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis. Sci. Rep. 13, 15250 (2023).","journal-title":"Sci. Rep."},{"key":"482_CR28","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis. Cell 183, 1264\u20131281.e1220 (2020).","journal-title":"Cell"},{"key":"482_CR29","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.2337\/db20-0038","volume":"69","author":"KM Simmons","year":"2020","unstructured":"Simmons, K. M. et al. Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02. Diabetes 69, 1763\u20131769 (2020).","journal-title":"Diabetes"},{"key":"482_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0140-6736(73)90970-7","volume":"2","author":"C Jersild","year":"1973","unstructured":"Jersild, C. et al. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 2, 1221\u20131225 (1973).","journal-title":"Lancet"},{"key":"482_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","volume":"37","author":"R Martin","year":"2021","unstructured":"Martin, R., Sospedra, M., Eiermann, T. & Olsson, T. Multiple sclerosis: doubling down on MHC. Trends Genet 37, 784\u2013797 (2021).","journal-title":"Trends Genet"},{"key":"482_CR32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/ng.3395","volume":"47","author":"L Moutsianas","year":"2015","unstructured":"Moutsianas, L. et al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat. Genet 47, 1107\u20131113 (2015).","journal-title":"Nat. Genet"},{"key":"482_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","volume":"8","author":"M Wieczorek","year":"2017","unstructured":"Wieczorek, M. et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Front Immunol. 8, 292 (2017).","journal-title":"Front Immunol."},{"key":"482_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tig.2020.01.008","volume":"36","author":"J Radwan","year":"2020","unstructured":"Radwan, J., Babik, W., Kaufman, J., Lenz, T. L. & Winternitz, J. Advances in the Evolutionary Understanding of MHC Polymorphism. Trends Genet 36, 298\u2013311 (2020).","journal-title":"Trends Genet"},{"key":"482_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-9994-2-16","volume":"2","author":"S Sommer","year":"2005","unstructured":"Sommer, S. The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool. 2, 16 (2005).","journal-title":"Front Zool."},{"key":"482_CR36","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1195271","volume":"330","author":"F Pereyra","year":"2010","unstructured":"Pereyra, F. et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551\u20131557 (2010).","journal-title":"Science"},{"key":"482_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm0496-405","volume":"2","author":"RA Kaslow","year":"1996","unstructured":"Kaslow, R. A. et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med 2, 405\u2013411 (1996).","journal-title":"Nat. Med"},{"key":"482_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ni.2342","volume":"13","author":"H Chen","year":"2012","unstructured":"Chen, H. et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat. Immunol. 13, 691\u2013700 (2012).","journal-title":"Nat. Immunol."},{"key":"482_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/35085576","volume":"412","author":"PJ Goulder","year":"2001","unstructured":"Goulder, P. J. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334\u2013338 (2001).","journal-title":"Nature"},{"key":"482_CR40","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1186\/ar571","volume":"4","author":"A McMichael","year":"2002","unstructured":"McMichael, A. & Bowness, P. HLA-B27: natural function and pathogenic role in spondyloarthritis. Arthritis Res 4, S153\u2013158 (2002).","journal-title":"Arthritis Res"},{"key":"482_CR41","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1172\/JCI25350","volume":"115","author":"A Suri","year":"2005","unstructured":"Suri, A., Walters, J. J., Gross, M. L. & Unanue, E. R. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J. Clin. Invest 115, 2268\u20132276 (2005).","journal-title":"J. Clin. Invest"},{"key":"482_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/329599a0","volume":"329","author":"JA Todd","year":"1987","unstructured":"Todd, J. A., Bell, J. I. & McDevitt, H. O. H. L. A.-D. Q. beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599\u2013604 (1987).","journal-title":"Nature"},{"key":"482_CR43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1074-7613(00)80220-4","volume":"12","author":"RR Latek","year":"2000","unstructured":"Latek, R. R. et al. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12, 699\u2013710 (2000).","journal-title":"Immunity"},{"key":"482_CR44","doi-asserted-by":"publisher","unstructured":"Gioia, L. et al. Position \u03b257 of I-A(g7) controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset. Sci Immunol 4, https:\/\/doi.org\/10.1126\/sciimmunol.aaw6329 (2019).","DOI":"10.1126\/sciimmunol.aaw6329"},{"key":"482_CR45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S0006-3495(91)82307-4","volume":"59","author":"RM Glaeser","year":"1991","unstructured":"Glaeser, R. M., Downing, K. H. & Jap, B. K. What spectroscopy can still tell us about the secondary structure of bacteriorhodopsin. Biophys. J. 59, 934\u2013938 (1991).","journal-title":"Biophys. J."},{"key":"482_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000205478","volume":"20","author":"J Dausset","year":"1958","unstructured":"Dausset, J. Iso-leuko-antibodies. Acta Haematol. 20, 156\u2013166 (1958).","journal-title":"Acta Haematol."},{"key":"482_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1126\/science.175.4019.273","volume":"175","author":"B Benacerraf","year":"1972","unstructured":"Benacerraf, B. & McDevitt, H. O. Histocompatibility-linked immune response genes. Science 175, 273\u2013279 (1972).","journal-title":"Science"},{"key":"482_CR48","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/00007890-196511000-00001","volume":"3","author":"J Dausset","year":"1965","unstructured":"Dausset, J., Rapaport, F. T., Colombani, J. & Feingold, N. A leucocyte group and its relationship to tissue histocompatibility in man. Transplantation 3, 701\u2013705 (1965).","journal-title":"Transplantation"},{"key":"482_CR49","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1073\/pnas.64.3.1095","volume":"64","author":"I Green","year":"1969","unstructured":"Green, I., Paul, W. E. & Benacerraf, B. Genetic control of immunological responsiveness in guinea pigs to 2,4-dinitrophenyl conjugates of poly-L-arginine, protamine, and poly-L-ornithine. Proc. Natl Acad. Sci. USA 64, 1095\u20131102 (1969).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"482_CR50","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1126\/science.163.3872.1207","volume":"163","author":"HO McDevitt","year":"1969","unstructured":"McDevitt, H. O. & Chinitz, A. Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type. Science 163, 1207\u20131208 (1969).","journal-title":"Science"},{"key":"482_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1084\/jem.122.3.517","volume":"122","author":"HO McDevitt","year":"1965","unstructured":"McDevitt, H. O. & Sela, M. Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. J. Exp. Med. 122, 517\u2013531 (1965).","journal-title":"J. Exp. Med."},{"key":"482_CR52","first-page":"548","volume":"1","author":"ML Tyan","year":"1969","unstructured":"Tyan, M. L., McDevitt, H. O. & Herzenberg, L. A. Genetic control of the antibody response to a synthetic polypeptide: transfer of response with spleen cells or lymphoid precursors. Transpl. Proc. 1, 548\u2013550 (1969).","journal-title":"Transpl. Proc."},{"key":"482_CR53","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1084\/jem.138.5.1266","volume":"138","author":"RM Zinkernagel","year":"1973","unstructured":"Zinkernagel, R. M. & Doherty, P. C. Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis. J. Exp. Med 138, 1266\u20131269 (1973).","journal-title":"J. Exp. Med"},{"key":"482_CR54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/329506a0","volume":"329","author":"PJ Bjorkman","year":"1987","unstructured":"Bjorkman, P. J. et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506\u2013512 (1987).","journal-title":"Nature"},{"key":"482_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1126\/science.274.5285.209","volume":"274","author":"KC Garcia","year":"1996","unstructured":"Garcia, K. C. et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274, 209\u2013219 (1996).","journal-title":"Science"},{"key":"482_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100631","volume":"22","author":"JR Prensner","year":"2023","unstructured":"Prensner, J. R. et al. What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome? Mol. Cell Proteom. 22, 100631 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101730","volume":"66","author":"CF Lichti","year":"2023","unstructured":"Lichti, C. F. & Wan, X. Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example. Semin Immunol. 66, 101730 (2023).","journal-title":"Semin Immunol."},{"key":"482_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2021.100042","volume":"11","author":"LE Stopfer","year":"2021","unstructured":"Stopfer, L. E., D\u2019Souza, A. D. & White, F. M. 1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs. Immunooncol Technol. 11, 100042 (2021).","journal-title":"Immunooncol Technol."},{"key":"482_CR59","doi-asserted-by":"publisher","first-page":"e0031021","DOI":"10.1128\/msystems.00310-21","volume":"6","author":"OK Leddy","year":"2021","unstructured":"Leddy, O. K., White, F. M. & Bryson, B. D. Leveraging Immunopeptidomics To Study and Combat Infectious Disease. mSystems 6, e0031021 (2021).","journal-title":"mSystems"},{"key":"482_CR60","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.1546328","volume":"255","author":"DF Hunt","year":"1992","unstructured":"Hunt, D. F. et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255, 1261\u20131263 (1992).","journal-title":"Science"},{"key":"482_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100479","volume":"3","author":"X Li","year":"2023","unstructured":"Li, X. et al. A microfluidics-enabled automated workflow of sample preparation for MS-based immunopeptidomics. Cell Rep. Methods 3, 100479 (2023).","journal-title":"Cell Rep. Methods"},{"key":"482_CR62","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41590-020-0623-7","volume":"21","author":"X Wan","year":"2020","unstructured":"Wan, X. et al. The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides. Nat. Immunol. 21, 455\u2013463 (2020).","journal-title":"Nat. Immunol."},{"key":"482_CR63","doi-asserted-by":"publisher","first-page":"100133","DOI":"10.1016\/j.mcpro.2021.100133","volume":"20","author":"S Klaeger","year":"2021","unstructured":"Klaeger, S. et al. Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples. Mol. Cell Proteom. 20, 100133 (2021).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42692-7","volume":"14","author":"N Hoenisch Gravel","year":"2023","unstructured":"Hoenisch Gravel, N. et al. TOF(IMS) mass spectrometry-based immunopeptidomics refines tumor antigen identification. Nat. Commun. 14, 7472 (2023).","journal-title":"Nat. Commun."},{"key":"482_CR65","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.csbj.2023.02.033","volume":"21","author":"PR Munday","year":"2023","unstructured":"Munday, P. R. et al. Immunolyser: A web-based computational pipeline for analysing and mining immunopeptidomic data. Comput Struct. Biotechnol. J. 21, 1678\u20131687 (2023).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"482_CR66","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkad1068","volume":"52","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. The SysteMHC Atlas v2.0, an updated resource for mass spectrometry-based immunopeptidomics. Nucleic Acids Res 52, D1062\u2013D1071 (2024).","journal-title":"Nucleic Acids Res"},{"key":"482_CR67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41587-021-01021-3","volume":"40","author":"T Ouspenskaia","year":"2022","unstructured":"Ouspenskaia, T. et al. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat. Biotechnol. 40, 209\u2013217 (2022).","journal-title":"Nat. Biotechnol."},{"key":"482_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102342","volume":"83","author":"J Holly","year":"2023","unstructured":"Holly, J. & Yewdell, J. W. Game of Omes: ribosome profiling expands the MHC-I immunopeptidome. Curr. Opin. Immunol. 83, 102342 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"482_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48322-0","volume":"15","author":"C Adams","year":"2024","unstructured":"Adams, C. et al. Fragment ion intensity prediction improves the identification rate of non-tryptic peptides in timsTOF. Nat. Commun. 15, 3956 (2024).","journal-title":"Nat. Commun."},{"key":"482_CR70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41592-019-0426-7","volume":"16","author":"S Gessulat","year":"2019","unstructured":"Gessulat, S. et al. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning. Nat. Methods 16, 509\u2013518 (2019).","journal-title":"Nat. Methods"},{"key":"482_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100266","volume":"21","author":"A Declercq","year":"2022","unstructured":"Declercq, A. et al. MS(2)Rescore: Data-Driven Rescoring Dramatically Boosts Immunopeptide Identification Rates. Mol. Cell Proteom. 21, 100266 (2022).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40129-9","volume":"14","author":"KL Yang","year":"2023","unstructured":"Yang, K. L. et al. MSBooster: improving peptide identification rates using deep learning-based features. Nat. Commun. 14, 4539 (2023).","journal-title":"Nat. Commun."},{"key":"482_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.157","volume":"5","author":"H Schuster","year":"2018","unstructured":"Schuster, H. et al. A tissue-based draft map of the murine MHC class I immunopeptidome. Sci. Data 5, 180157 (2018).","journal-title":"Sci. Data"},{"key":"482_CR74","doi-asserted-by":"publisher","unstructured":"Ramazi, S. & Zahiri, J. Posttranslational modifications in proteins: resources, tools and prediction methods. Database (Oxford) 2021, https:\/\/doi.org\/10.1093\/database\/baab012 (2021).","DOI":"10.1093\/database\/baab012"},{"key":"482_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.101053","volume":"86","author":"EQ Jennings","year":"2022","unstructured":"Jennings, E. Q., Fritz, K. S. & Galligan, J. J. Biochemical genesis of enzymatic and non-enzymatic post-translational modifications. Mol. Asp. Med 86, 101053 (2022).","journal-title":"Mol. Asp. Med"},{"key":"482_CR76","doi-asserted-by":"publisher","unstructured":"Haro, I., Sanmart\u00ed, R. & G\u00f3mara, M. J. Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. Int J Mol Sci 23, https:\/\/doi.org\/10.3390\/ijms232415803 (2022).","DOI":"10.3390\/ijms232415803"},{"key":"482_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-0716-2317-6_11","volume":"2499","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Systematic Characterization of Lysine Post-translational Modification Sites Using MUscADEL. Methods Mol. Biol. 2499, 205\u2013219 (2022).","journal-title":"Methods Mol. Biol."},{"key":"482_CR78","doi-asserted-by":"publisher","first-page":"D471","DOI":"10.1093\/nar\/gkab1017","volume":"50","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res 50, D471\u2013D479 (2022).","journal-title":"Nucleic Acids Res"},{"key":"482_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100430","volume":"3","author":"Y Yan","year":"2023","unstructured":"Yan, Y. et al. MIND-S is a deep-learning prediction model for elucidating protein post-translational modifications in human diseases. Cell Rep. Methods 3, 100430 (2023).","journal-title":"Cell Rep. Methods"},{"key":"482_CR80","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.183.2.527","volume":"183","author":"JC Skipper","year":"1996","unstructured":"Skipper, J. C. et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med 183, 527\u2013534 (1996).","journal-title":"J. Exp. Med"},{"key":"482_CR81","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.coi.2005.11.015","volume":"18","author":"VH Engelhard","year":"2006","unstructured":"Engelhard, V. H., Altrich-Vanlith, M., Ostankovitch, M. & Zarling, A. L. Post-translational modifications of naturally processed MHC-binding epitopes. Curr. Opin. Immunol. 18, 92\u201397 (2006).","journal-title":"Curr. Opin. Immunol."},{"key":"482_CR82","doi-asserted-by":"publisher","first-page":"14889","DOI":"10.1073\/pnas.0604045103","volume":"103","author":"AL Zarling","year":"2006","unstructured":"Zarling, A. L. et al. Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc. Natl Acad. Sci. USA 103, 14889\u201314894 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"482_CR83","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1126\/science.aaf4384","volume":"354","author":"J Liepe","year":"2016","unstructured":"Liepe, J. et al. A large fraction of HLA class I ligands are proteasome-generated spliced peptides. Science 354, 354\u2013358 (2016).","journal-title":"Science"},{"key":"482_CR84","doi-asserted-by":"publisher","unstructured":"Faridi, P. et al. A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands. Sci Immunol 3, https:\/\/doi.org\/10.1126\/sciimmunol.aar3947 (2018).","DOI":"10.1126\/sciimmunol.aar3947"},{"key":"482_CR85","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1074\/mcp.RA118.000877","volume":"17","author":"R Mylonas","year":"2018","unstructured":"Mylonas, R. et al. Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome. Mol. Cell Proteom. 17, 2347\u20132357 (2018).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR86","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1074\/mcp.RA119.001846","volume":"19","author":"S Mei","year":"2020","unstructured":"Mei, S. et al. Immunopeptidomic analysis reveals that deamidated HLA-bound peptides arise predominantly from deglycosylated precursors. Mol. Cell Proteom. 19, 1236\u20131247 (2020).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR87","doi-asserted-by":"publisher","first-page":"E323","DOI":"10.1073\/pnas.1101892108","volume":"108","author":"A Dalet","year":"2011","unstructured":"Dalet, A. et al. An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc. Natl Acad. Sci. USA 108, E323\u2013E331 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"482_CR88","first-page":"349","volume":"18","author":"Z Rolfs","year":"2019","unstructured":"Rolfs, Z., Solntsev, S. K., Shortreed, M. R., Frey, B. L. & Smith, L. M. Global Identification of Post-Translationally Spliced Peptides with Neo-Fusion. J. Proteome Res 18, 349\u2013358 (2019).","journal-title":"J. Proteome Res"},{"key":"482_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.861609","volume":"10","author":"T Sandalova","year":"2022","unstructured":"Sandalova, T., Sala, B. M. & Achour, A. Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition. Front Chem. 10, 861609 (2022).","journal-title":"Front Chem."},{"key":"482_CR90","doi-asserted-by":"publisher","unstructured":"Prensner, J. R. et al. What can Ribo-seq and proteomics tell us about the non-canonical proteome? bioRxiv, https:\/\/doi.org\/10.1101\/2023.05.16.541049 (2023).","DOI":"10.1101\/2023.05.16.541049"},{"key":"482_CR91","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1158\/2326-6066.CIR-22-0621","volume":"11","author":"G Bedran","year":"2023","unstructured":"Bedran, G. et al. The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I-Associated Peptides. Cancer Immunol. Res 11, 747\u2013762 (2023).","journal-title":"Cancer Immunol. Res"},{"key":"482_CR92","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s42485-021-00066-x","volume":"12","author":"KK Mangalaparthi","year":"2021","unstructured":"Mangalaparthi, K. K. et al. Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I. J. Proteins Proteom. 12, 151\u2013160 (2021).","journal-title":"J. Proteins Proteom."},{"key":"482_CR93","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.adg3925","volume":"379","author":"L Santambrogio","year":"2023","unstructured":"Santambrogio, L. Autoimmunity to the modified self. Science 379, 1092\u20131093 (2023).","journal-title":"Science"},{"key":"482_CR94","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1074\/mcp.M900540-MCP200","volume":"9","author":"D Houde","year":"2010","unstructured":"Houde, D., Peng, Y., Berkowitz, S. A. & Engen, J. R. Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol. Cell Proteom. 9, 1716\u20131728 (2010).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1373","volume":"13","author":"Y Zhai","year":"2023","unstructured":"Zhai, Y. & Zhu, P. Post-translationally modified neoantigens: Promising targets for diagnostic strategy of autoimmune diseases. Clin. Transl. Med 13, e1373 (2023).","journal-title":"Clin. Transl. Med"},{"key":"482_CR96","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.4049\/jimmunol.1000629","volume":"185","author":"DK Cole","year":"2010","unstructured":"Cole, D. K. et al. Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J. Immunol. 185, 2600\u20132610 (2010).","journal-title":"J. Immunol."},{"key":"482_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02763-y","volume":"9","author":"B Raposo","year":"2018","unstructured":"Raposo, B. et al. T cells specific for post-translational modifications escape intrathymic tolerance induction. Nat. Commun. 9, 353 (2018).","journal-title":"Nat. Commun."},{"key":"482_CR98","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00109-009-0526-4","volume":"87","author":"J Petersen","year":"2009","unstructured":"Petersen, J., Purcell, A. W. & Rossjohn, J. Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J. Mol. Med. (Berl.) 87, 1045\u20131051 (2009).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"482_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103107","volume":"24","author":"X Yi","year":"2021","unstructured":"Yi, X. et al. caAtlas: An immunopeptidome atlas of human cancer. iScience 24, 103107 (2021).","journal-title":"iScience"},{"key":"482_CR100","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41592-020-0867-z","volume":"18","author":"AV Joglekar","year":"2021","unstructured":"Joglekar, A. V. & Li, G. T cell antigen discovery. Nat. Methods 18, 873\u2013880 (2021).","journal-title":"Nat. Methods"},{"key":"482_CR101","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41592-024-02255-0","volume":"21","author":"PM Zdinak","year":"2024","unstructured":"Zdinak, P. M. et al. De novo identification of CD4(+) T cell epitopes. Nat. Methods 21, 846\u2013856 (2024).","journal-title":"Nat. Methods"},{"key":"482_CR102","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ni.1844","volume":"11","author":"BD Stadinski","year":"2010","unstructured":"Stadinski, B. D. et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 11, 225\u2013231 (2010).","journal-title":"Nat. Immunol."},{"key":"482_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaut.2016.10.007","volume":"78","author":"TA Wiles","year":"2017","unstructured":"Wiles, T. A. et al. An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse. J. Autoimmun. 78, 11\u201318 (2017).","journal-title":"J. Autoimmun."},{"key":"482_CR104","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","volume":"464","author":"JA Bluestone","year":"2010","unstructured":"Bluestone, J. A., Herold, K. & Eisenbarth, G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464, 1293\u20131300 (2010).","journal-title":"Nature"},{"key":"482_CR105","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/POC.0000000000000125","volume":"16","author":"L Kahanovitz","year":"2017","unstructured":"Kahanovitz, L., Sluss, P. M. & Russell, S. J. Type 1 Diabetes - A Clinical Perspective. Point Care 16, 37\u201340 (2017).","journal-title":"Point Care"},{"key":"482_CR106","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2337\/dbi18-0066","volume":"68","author":"AW Purcell","year":"2019","unstructured":"Purcell, A. W., Sechi, S. & DiLorenzo, T. P. The evolving landscape of autoantigen discovery and characterization in type 1 diabetes. Diabetes 68, 879\u2013886 (2019).","journal-title":"Diabetes"},{"key":"482_CR107","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson, M. S. & Bluestone, J. A. The NOD mouse: a model of immune dysregulation. Annu Rev. Immunol. 23, 447\u2013485 (2005).","journal-title":"Annu Rev. Immunol."},{"key":"482_CR108","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2015.08.019","volume":"66","author":"JA Pearson","year":"2016","unstructured":"Pearson, J. A., Wong, F. S. & Wen, L. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J. Autoimmun. 66, 76\u201388 (2016).","journal-title":"J. Autoimmun."},{"key":"482_CR109","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1084\/jem.183.1.67","volume":"183","author":"FS Wong","year":"1996","unstructured":"Wong, F. S., Visintin, I., Wen, L., Flavell, R. A. & Janeway, C. A. Jr. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med 183, 67\u201376 (1996).","journal-title":"J. Exp. Med"},{"key":"482_CR110","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev-immunol-032712-095941","volume":"32","author":"ER Unanue","year":"2014","unstructured":"Unanue, E. R. Antigen presentation in the autoimmune diabetes of the NOD mouse. Annu Rev. Immunol. 32, 579\u2013608 (2014).","journal-title":"Annu Rev. Immunol."},{"key":"482_CR111","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.2337\/db11-1333","volume":"61","author":"NL Dudek","year":"2012","unstructured":"Dudek, N. L. et al. Constitutive and inflammatory immunopeptidome of pancreatic \u03b2-cells. Diabetes 61, 3018\u20133025 (2012).","journal-title":"Diabetes"},{"key":"482_CR112","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00125-021-05619-9","volume":"65","author":"E Quesada-Masachs","year":"2022","unstructured":"Quesada-Masachs, E. et al. Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes. Diabetologia 65, 387\u2013401 (2022).","journal-title":"Diabetologia"},{"key":"482_CR113","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2337\/db18-0686","volume":"68","author":"MA Russell","year":"2019","unstructured":"Russell, M. A. et al. HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet \u03b2-Cells From Donors With Type 1 Diabetes. Diabetes 68, 988\u20131001 (2019).","journal-title":"Diabetes"},{"key":"482_CR114","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1002\/eji.201445378","volume":"45","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. et al. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate. Eur. J. Immunol. 45, 2494\u20132503 (2015).","journal-title":"Eur. J. Immunol."},{"key":"482_CR115","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbadis.2006.05.001","volume":"1762","author":"PE Harris","year":"2006","unstructured":"Harris, P. E. et al. Effect of interferon alpha on MHC class II gene expression in ex vivo human islet tissue. Biochim Biophys. Acta 1762, 627\u2013635 (2006).","journal-title":"Biochim Biophys. Acta"},{"key":"482_CR116","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","volume":"28","author":"S Gonzalez-Duque","year":"2018","unstructured":"Gonzalez-Duque, S. et al. Conventional and Neo-antigenic Peptides Presented by \u03b2 Cells Are Targeted by Circulating Na\u00efve CD8+ T Cells in Type 1 Diabetic and Healthy Donors. Cell Metab. 28, 946\u2013960.e946 (2018).","journal-title":"Cell Metab."},{"key":"482_CR117","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.2337\/db11-1520","volume":"61","author":"D Kronenberg","year":"2012","unstructured":"Kronenberg, D. et al. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill \u03b2-cells. Diabetes 61, 1752\u20131759 (2012).","journal-title":"Diabetes"},{"key":"482_CR118","first-page":"3390","volume":"118","author":"A Skowera","year":"2008","unstructured":"Skowera, A. et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J. Clin. Invest 118, 3390\u20133402 (2008).","journal-title":"J. Clin. Invest"},{"key":"482_CR119","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1021\/acs.jproteome.8b00875","volume":"18","author":"TA Wiles","year":"2019","unstructured":"Wiles, T. A. et al. Identification of Hybrid Insulin Peptides (HIPs) in Mouse and Human Islets by Mass Spectrometry. J. Proteome Res 18, 814\u2013825 (2019).","journal-title":"J. Proteome Res"},{"key":"482_CR120","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.aad2791","volume":"351","author":"T Delong","year":"2016","unstructured":"Delong, T. et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351, 711\u2013714 (2016).","journal-title":"Science"},{"key":"482_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1313.001","volume":"1050","author":"HA Doyle","year":"2005","unstructured":"Doyle, H. A. & Mamula, M. J. Posttranslational modifications of self-antigens. Ann. N. Y Acad. Sci. 1050, 1\u20139 (2005).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"482_CR122","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/db11-1675","volume":"61","author":"JL Dunne","year":"2012","unstructured":"Dunne, J. L., Overbergh, L., Purcell, A. W. & Mathieu, C. Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure? Diabetes 61, 1907\u20131914 (2012).","journal-title":"Diabetes"},{"key":"482_CR123","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0889-857X(05)70137-X","volume":"26","author":"KE Sullivan","year":"2000","unstructured":"Sullivan, K. E. Genetics of systemic lupus erythematosus. Clin. Implic. Rheum. Dis. Clin. North Am. 26, 229\u2013256 (2000). v-vi.","journal-title":"Clin. Implic. Rheum. Dis. Clin. North Am."},{"key":"482_CR124","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/gene.2009.39","volume":"10","author":"KL Moser","year":"2009","unstructured":"Moser, K. L., Kelly, J. A., Lessard, C. J. & Harley, J. B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 10, 373\u2013379 (2009).","journal-title":"Genes Immun."},{"key":"482_CR125","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1357-4310(00)01798-6","volume":"6","author":"GC Tsokos","year":"2000","unstructured":"Tsokos, G. C. & Kammer, G. M. Molecular aberrations in human systemic lupus erythematosus. Mol. Med Today 6, 418\u2013424 (2000).","journal-title":"Mol. Med Today"},{"key":"482_CR126","first-page":"1563","volume":"33","author":"M Faurschou","year":"2006","unstructured":"Faurschou, M., Starklint, H., Halberg, P. & Jacobsen, S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J. Rheumatol. 33, 1563\u20131569 (2006).","journal-title":"J. Rheumatol."},{"key":"482_CR127","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/art.40396","volume":"70","author":"S Karrar","year":"2018","unstructured":"Karrar, S. & Cunninghame Graham, D. S. Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol. 70, 496\u2013507 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"482_CR128","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos, G. C., Lo, M. S., Costa Reis, P. & Sullivan, K. E. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat. Rev. Rheumatol. 12, 716\u2013730 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"482_CR129","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.10762","volume":"48","author":"G Riemekasten","year":"2003","unstructured":"Riemekasten, G. et al. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies. Arthritis Rheum. 48, 475\u2013485 (2003).","journal-title":"Arthritis Rheum."},{"key":"482_CR130","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/rheumatology\/keh688","volume":"44","author":"G Riemekasten","year":"2005","unstructured":"Riemekasten, G. & Hahn, B. H. Key autoantigens in SLE. Rheumatol. (Oxf.) 44, 975\u2013982 (2005).","journal-title":"Rheumatol. (Oxf.)"},{"key":"482_CR131","doi-asserted-by":"publisher","unstructured":"Navarro Quiroz, E. et al. Epigenetic Mechanisms and Posttranslational Modifications in Systemic Lupus Erythematosus. Int J Mol Sci 20, https:\/\/doi.org\/10.3390\/ijms20225679 (2019).","DOI":"10.3390\/ijms20225679"},{"key":"482_CR132","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4730","volume":"6","author":"R Madda","year":"2018","unstructured":"Madda, R., Lin, S. C., Sun, W. H. & Huang, S. L. Plasma proteomic analysis of systemic lupus erythematosus patients using liquid chromatography\/tandem mass spectrometry with label-free quantification. PeerJ 6, e4730 (2018).","journal-title":"PeerJ"},{"key":"482_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103134","volume":"142","author":"JA Reynolds","year":"2024","unstructured":"Reynolds, J. A., Li, Y., Herlitz, L., Mohan, C. & Putterman, C. Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum. J. Autoimmun. 142, 103134 (2024).","journal-title":"J. Autoimmun."},{"key":"482_CR134","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/jcmm.13031","volume":"21","author":"O Nicolaou","year":"2017","unstructured":"Nicolaou, O. et al. Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review. J. Cell Mol. Med 21, 993\u20131012 (2017).","journal-title":"J. Cell Mol. Med"},{"key":"482_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78223-3","volume":"10","author":"S Tesch","year":"2020","unstructured":"Tesch, S. et al. Identification and characterization of antigen-specific CD4(+) T cells targeting renally expressed antigens in human lupus nephritis with two independent methods. Sci. Rep. 10, 21312 (2020).","journal-title":"Sci. Rep."},{"key":"482_CR136","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.4049\/jimmunol.164.9.4697","volume":"164","author":"JH Freed","year":"2000","unstructured":"Freed, J. H., Marrs, A., VanderWall, J., Cohen, P. L. & Eisenberg, R. A. MHC class II-bound self peptides from autoimmune MRL\/lpr mice reveal potential T cell epitopes for autoantibody production in murine systemic lupus erythematosus. J. Immunol. 164, 4697\u20134705 (2000).","journal-title":"J. Immunol."},{"key":"482_CR137","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1126\/science.1319610","volume":"256","author":"DF Hunt","year":"1992","unstructured":"Hunt, D. F. et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256, 1817\u20131820 (1992).","journal-title":"Science"},{"key":"482_CR138","doi-asserted-by":"publisher","unstructured":"Omelchenko, A. A. et al. Sliding Window INteraction Grammar (SWING): a generalized interaction language model for peptide and protein interactions. bioRxiv, https:\/\/doi.org\/10.1101\/2024.05.01.592062 (2024).","DOI":"10.1101\/2024.05.01.592062"},{"key":"482_CR139","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2018","unstructured":"Bullock, J. et al. Rheumatoid arthritis: a brief overview of the treatment. Med Princ. Pr. 27, 501\u2013507 (2018).","journal-title":"Med Princ. Pr."},{"key":"482_CR140","doi-asserted-by":"publisher","first-page":"102392","DOI":"10.1016\/j.jaut.2019.102392","volume":"110","author":"MAM van Delft","year":"2020","unstructured":"van Delft, M. A. M. & Huizinga, T. W. J. An overview of autoantibodies in rheumatoid arthritis. J. Autoimmun. 110, 102392 (2020).","journal-title":"J. Autoimmun."},{"key":"482_CR141","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42358-018-0042-8","volume":"59","author":"S de Brito Rocha","year":"2019","unstructured":"de Brito Rocha, S., Baldo, D. C. & Andrade, L. E. C. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Adv. Rheumatol. 59, 2 (2019).","journal-title":"Adv. Rheumatol."},{"key":"482_CR142","first-page":"144","volume":"9","author":"BI Gavril\u0103","year":"2016","unstructured":"Gavril\u0103, B. I., Ciofu, C. & Stoica, V. Biomarkers in Rheumatoid Arthritis, what is new? J. Med Life 9, 144\u2013148 (2016).","journal-title":"J. Med Life"},{"key":"482_CR143","first-page":"S4","volume":"25","author":"AP Cope","year":"2007","unstructured":"Cope, A. P., Schulze-Koops, H. & Aringer, M. The central role of T cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 25, S4\u2013S11 (2007).","journal-title":"Clin. Exp. Rheumatol."},{"key":"482_CR144","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.rdc.2017.04.003","volume":"43","author":"V van Drongelen","year":"2017","unstructured":"van Drongelen, V. & Holoshitz, J. Human leukocyte antigen-disease associations in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 43, 363\u2013376 (2017).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"482_CR145","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fimmu.2019.00353","volume":"10","author":"K Chemin","year":"2019","unstructured":"Chemin, K., Gerstner, C. & Malmstr\u00f6m, V. Effector functions of CD4+ T cells at the site of local autoimmune inflammation-lessons from rheumatoid arthritis. Front Immunol. 10, 353 (2019).","journal-title":"Front Immunol."},{"key":"482_CR146","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2412","volume":"10","author":"AP Cope","year":"2008","unstructured":"Cope, A. P. T cells in rheumatoid arthritis. Arthritis Res Ther. 10, S1 (2008).","journal-title":"Arthritis Res Ther."},{"key":"482_CR147","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/BOR.0b013e328336ba63","volume":"22","author":"J Holoshitz","year":"2010","unstructured":"Holoshitz, J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr. Opin. Rheumatol. 22, 293\u2013298 (2010).","journal-title":"Curr. Opin. Rheumatol."},{"key":"482_CR148","doi-asserted-by":"publisher","first-page":"689698","DOI":"10.3389\/fmed.2021.689698","volume":"8","author":"VC Rom\u00e3o","year":"2021","unstructured":"Rom\u00e3o, V. C. & Fonseca, J. E. Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review. Front Med (Lausanne) 8, 689698 (2021).","journal-title":"Front Med (Lausanne)"},{"key":"482_CR149","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1084\/jem.181.5.1597","volume":"181","author":"KW Wucherpfennig","year":"1995","unstructured":"Wucherpfennig, K. W. & Strominger, J. L. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181, 1597\u20131601 (1995).","journal-title":"J. Exp. Med."},{"key":"482_CR150","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.4049\/jimmunol.146.4.1093","volume":"146","author":"HR Bhayani","year":"1991","unstructured":"Bhayani, H. R. & Hedrick, S. M. The role of polymorphic amino acids of the MHC molecule in the selection of the T cell repertoire. J. Immunol. 146, 1093\u20131098 (1991).","journal-title":"J. Immunol."},{"key":"482_CR151","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/imm.12640","volume":"149","author":"H Nguyen","year":"2016","unstructured":"Nguyen, H. & James, E. A. Immune recognition of citrullinated epitopes. Immunology 149, 131\u2013138 (2016).","journal-title":"Immunology"},{"key":"482_CR152","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M110.002477","volume":"10","author":"RJ Seward","year":"2011","unstructured":"Seward, R. J., Drouin, E. E., Steere, A. C. & Costello, C. E. Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis. Mol. Cell Proteom. 10, M110.002477 (2011).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR153","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/acs.jproteome.6b00386","volume":"16","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Immunogenic HLA-DR-presented self-peptides identified directly from clinical samples of synovial tissue, synovial fluid, or peripheral blood in patients with rheumatoid arthritis or lyme arthritis. J. Proteome Res 16, 122\u2013136 (2017).","journal-title":"J. Proteome Res"},{"key":"482_CR154","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/art.39736","volume":"68","author":"E Scholz","year":"2016","unstructured":"Scholz, E. et al. A Comparative Analysis of the Peptide Repertoires of HLA-DR Molecules Differentially Associated With Rheumatoid Arthritis. Arthritis Rheumatol. 68, 2412\u20132421 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"482_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36620-y","volume":"14","author":"AM Curran","year":"2023","unstructured":"Curran, A. M. et al. Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis. Nat. Commun. 14, 1061 (2023).","journal-title":"Nat. Commun."},{"key":"482_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835454","volume":"13","author":"S Kaabinejadian","year":"2022","unstructured":"Kaabinejadian, S. et al. Accurate MHC motif deconvolution of immunopeptidomics data reveals a significant contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome. Front Immunol. 13, 835454 (2022).","journal-title":"Front Immunol."},{"key":"482_CR157","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1371\/journal.pone.0000796","volume":"2","author":"M Nielsen","year":"2007","unstructured":"Nielsen, M. et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2, e796 (2007).","journal-title":"PLoS One"},{"key":"482_CR158","doi-asserted-by":"publisher","first-page":"e1000107","DOI":"10.1371\/journal.pcbi.1000107","volume":"4","author":"M Nielsen","year":"2008","unstructured":"Nielsen, M. et al. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol. 4, e1000107 (2008).","journal-title":"PLoS Comput Biol."},{"key":"482_CR159","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/annrheumdis-2021-220371","volume":"81","author":"J Maggi","year":"2022","unstructured":"Maggi, J. et al. Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis. Ann. Rheum. Dis. 81, 1096\u20131105 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"482_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100540","volume":"22","author":"Z Xu","year":"2023","unstructured":"Xu, Z. et al. Integrative Proteomics and N-glycoproteomics analyses of rheumatoid arthritis synovium reveal immune-associated glycopeptides. Mol. Cell Proteom. 22, 100540 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR161","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.2337\/db20-0013","volume":"69","author":"ME Azoury","year":"2020","unstructured":"Azoury, M. E. et al. Peptides Derived From Insulin Granule Proteins Are Targeted by CD8(+) T Cells Across MHC Class I Restrictions in Humans and NOD Mice. Diabetes 69, 2678\u20132690 (2020).","journal-title":"Diabetes"},{"key":"482_CR162","doi-asserted-by":"publisher","unstructured":"Dolton, G. et al. HLA A*24:02-restricted T cell receptors cross-recognize bacterial and preproinsulin peptides in type 1 diabetes. J Clin Invest 134, https:\/\/doi.org\/10.1172\/jci164535 (2024).","DOI":"10.1172\/jci164535"},{"key":"482_CR163","doi-asserted-by":"publisher","unstructured":"Anderson, A. M. et al. Human islet T cells are highly reactive to preproinsulin in type 1 diabetes. Proc Natl Acad Sci USA 118, https:\/\/doi.org\/10.1073\/pnas.2107208118 (2021).","DOI":"10.1073\/pnas.2107208118"},{"key":"482_CR164","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jaut.2011.05.012","volume":"37","author":"WW Unger","year":"2011","unstructured":"Unger, W. W. et al. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers. J. Autoimmun. 37, 151\u2013159 (2011).","journal-title":"J. Autoimmun."},{"key":"482_CR165","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.1073\/pnas.0504230102","volume":"102","author":"A Toma","year":"2005","unstructured":"Toma, A. et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc. Natl Acad. Sci. USA 102, 10581\u201310586 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"482_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.622647","volume":"12","author":"LG Landry","year":"2021","unstructured":"Landry, L. G. et al. Proinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ Donors. Front Endocrinol. (Lausanne) 12, 622647 (2021).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"482_CR167","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2337\/db12-1214","volume":"63","author":"M van Lummel","year":"2014","unstructured":"van Lummel, M. et al. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes. Diabetes 63, 237\u2013247 (2014).","journal-title":"Diabetes"},{"key":"482_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107612","volume":"300","author":"MT Tran","year":"2024","unstructured":"Tran, M. T. et al. A structural basis of T cell cross-reactivity to native and spliced self-antigens presented by HLA-DQ8. J. Biol. Chem. 300, 107612 (2024).","journal-title":"J. Biol. Chem."},{"key":"482_CR169","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2337\/db23-0588","volume":"73","author":"A Callebaut","year":"2024","unstructured":"Callebaut, A. et al. CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets. Diabetes 73, 728\u2013742 (2024).","journal-title":"Diabetes"},{"key":"482_CR170","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.2337\/db19-0620","volume":"69","author":"D Arribas-Layton","year":"2020","unstructured":"Arribas-Layton, D. et al. Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01. Diabetes 69, 1492\u20131502 (2020).","journal-title":"Diabetes"},{"key":"482_CR171","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cellimm.2005.06.010","volume":"235","author":"BR Berner","year":"2005","unstructured":"Berner, B. R. et al. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. Cell Immunol. 235, 29\u201338 (2005).","journal-title":"Cell Immunol."},{"key":"482_CR172","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0198-8859(99)00184-6","volume":"61","author":"H Ito","year":"2000","unstructured":"Ito, H. et al. Analysis of T cell responses to the beta 2-glycoprotein I-derived peptide library in patients with anti-beta 2-glycoprotein I antibody-associated autoimmunity. Hum. Immunol. 61, 366\u2013377 (2000).","journal-title":"Hum. Immunol."},{"key":"482_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45056-x","volume":"15","author":"PJ Eggenhuizen","year":"2024","unstructured":"Eggenhuizen, P. J. et al. Smith-specific regulatory T cells halt the progression of lupus nephritis. Nat. Commun. 15, 899 (2024).","journal-title":"Nat. Commun."},{"key":"482_CR174","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.4049\/jimmunol.169.6.3429","volume":"169","author":"EL Greidinger","year":"2002","unstructured":"Greidinger, E. L. et al. T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein. J. Immunol. 169, 3429\u20133437 (2002).","journal-title":"J. Immunol."},{"key":"482_CR175","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1172\/JCI6801","volume":"104","author":"L Lu","year":"1999","unstructured":"Lu, L., Kaliyaperumal, A., Boumpas, D. T. & Datta, S. K. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J. Clin. Invest 104, 345\u2013355 (1999).","journal-title":"J. Clin. Invest"},{"key":"482_CR176","doi-asserted-by":"publisher","unstructured":"Kanjana, K. et al. Autoimmunity to synovial extracellular matrix proteins in patients with postinfectious Lyme arthritis. J Clin Invest 133, https:\/\/doi.org\/10.1172\/jci161170 (2023).","DOI":"10.1172\/jci161170"},{"key":"482_CR177","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/brain\/awt108","volume":"136","author":"M Mohme","year":"2013","unstructured":"Mohme, M. et al. HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis. Brain 136, 1783\u20131798 (2013).","journal-title":"Brain"},{"key":"482_CR178","doi-asserted-by":"publisher","unstructured":"Lee, M. N. & Meyerson, M. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells. Sci Immunol 6, https:\/\/doi.org\/10.1126\/sciimmunol.abf4001 (2021).","DOI":"10.1126\/sciimmunol.abf4001"},{"key":"482_CR179","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410340313","volume":"34","author":"N Joshi","year":"1993","unstructured":"Joshi, N., Usuku, K. & Hauser, S. L. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage. Ann. Neurol. 34, 385\u2013393 (1993).","journal-title":"Ann. Neurol."},{"key":"482_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-94","volume":"10","author":"F Lolli","year":"2013","unstructured":"Lolli, F. et al. Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. J. Neuroinflammation 10, 94 (2013).","journal-title":"J. Neuroinflammation"},{"key":"482_CR181","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1074\/mcp.M900001-MCP200","volume":"8","author":"N Fissolo","year":"2009","unstructured":"Fissolo, N. et al. Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol. Cell Proteom. 8, 2090\u20132101 (2009).","journal-title":"Mol. Cell Proteom."},{"key":"482_CR182","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","volume":"612","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 612, 771\u2013777 (2022).","journal-title":"Nature"},{"key":"482_CR183","doi-asserted-by":"publisher","first-page":"27189","DOI":"10.1074\/jbc.M802818200","volume":"283","author":"A Beltrami","year":"2008","unstructured":"Beltrami, A. et al. Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes. J. Biol. Chem. 283, 27189\u201327199 (2008).","journal-title":"J. Biol. Chem."},{"key":"482_CR184","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1084\/jem.20151093","volume":"212","author":"A Arakawa","year":"2015","unstructured":"Arakawa, A. et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J. Exp. Med 212, 2203\u20132212 (2015).","journal-title":"J. Exp. Med"},{"key":"482_CR185","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdermsci.2005.01.001","volume":"38","author":"Z Shen","year":"2005","unstructured":"Shen, Z., Wang, G., Fan, J. Y., Li, W. & Liu, Y. F. HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis. J. Dermatol Sci. 38, 25\u201339 (2005).","journal-title":"J. Dermatol Sci."},{"key":"482_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6621","volume":"5","author":"R Lande","year":"2014","unstructured":"Lande, R. et al. The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat. Commun. 5, 5621 (2014).","journal-title":"Nat. Commun."},{"key":"482_CR187","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/art.41248","volume":"72","author":"E Tiniakou","year":"2020","unstructured":"Tiniakou, E. et al. Definition of naturally processed peptides reveals convergent presentation of autoantigenic topoisomerase i epitopes in scleroderma. Arthritis Rheumatol. 72, 1375\u20131384 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"482_CR188","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00251-014-0819-9","volume":"67","author":"E Bergseng","year":"2015","unstructured":"Bergseng, E. et al. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics 67, 73\u201384 (2015).","journal-title":"Immunogenetics"}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00482-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00482-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00482-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T15:15:04Z","timestamp":1737386104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-024-00482-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":188,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1038\/s41540-024-00482-x","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}